• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence.

作者信息

Carnemolla B, Leprini A, Allemanni G, Saginati M, Zardi L

机构信息

Laboratory of Cell Biology, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

出版信息

J Biol Chem. 1992 Dec 5;267(34):24689-92.

PMID:1280266
Abstract

We have previously reported an anti-fibronectin monoclonal antibody (mAb) (BC-1) which reacts with an ED-B-containing beta-galactosidase-fibronectin fusion protein but not with an identical beta-galactosidase-fibronectin fusion protein in which the ED-B sequence is omitted. In further experiments aimed at localizing more precisely the epitope recognized by this mAb, we demonstrate that 1) the mAb BC-1 is indeed specific for ED-B-containing fibronectin (FN) molecules even though the epitope recognized by this mAb is localized on the type III homology repeat 7 (the one which precedes the ED-B sequence) and 2) in fibronectin molecules lacking the ED-B sequence, this epitope is masked. We further demonstrate that, to mask the epitope recognized by the mAb BC-1, the presence of at least half of the FN type III homology repeat 9 is necessary. We also report the production of the mAb IST-6 which recognizes only FN molecules in which the ED-B sequence is lacking. These data clearly demonstrate that the presence of the ED-B sequence within FN molecules generates conformational modification in the central part of the molecules that unmasks previously cryptic sequences and masks others.

摘要

相似文献

1
The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence.
J Biol Chem. 1992 Dec 5;267(34):24689-92.
2
Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8.纤维连接蛋白的血管生成相关额外结构域 B 的选择性剪接调节了第 8 型重复 3 结构域 B-C 环的可及性。
PLoS One. 2010 Feb 10;5(2):e9145. doi: 10.1371/journal.pone.0009145.
3
C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8.C6:一种针对位于癌胚性外显子 B 与重复 III8 之间界面的纤连蛋白表位的单克隆抗体。
PLoS One. 2016 Feb 11;11(2):e0148103. doi: 10.1371/journal.pone.0148103. eCollection 2016.
4
Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E. coli.
FEBS Lett. 1987 May 11;215(2):269-73. doi: 10.1016/0014-5793(87)80160-6.
5
NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis.人癌胚纤连蛋白ED-B结构域的核磁共振结构,血管生成的特异性标志物
Structure. 1999 Apr 15;7(4):381-90. doi: 10.1016/s0969-2126(99)80051-3.
6
Procedure for the purification of the fibronectin proteolytic fragments containing the ED-B oncofetal domain.含有ED-B癌胚结构域的纤连蛋白蛋白水解片段的纯化步骤。
Anal Biochem. 1991 Feb 1;192(2):372-9. doi: 10.1016/0003-2697(91)90551-4.
7
Identification of two amino acids within the EIIIA (ED-A) segment of fibronectin constituting the epitope for two function-blocking monoclonal antibodies.鉴定纤连蛋白EIIIA(ED-A)片段内构成两种功能阻断单克隆抗体表位的两个氨基酸。
J Biol Chem. 1999 Jun 18;274(25):17876-84. doi: 10.1074/jbc.274.25.17876.
8
The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.含有ED-B癌胚结构域的纤连蛋白异构体:血管生成的标志物。
Int J Cancer. 1994 Dec 1;59(5):612-8. doi: 10.1002/ijc.2910590507.
9
Conformational transitions in the cell binding domain of fibronectin.
Biochemistry. 1995 Apr 4;34(13):4457-66. doi: 10.1021/bi00013a039.
10
Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies.人腱生蛋白:一级结构、前体mRNA剪接模式以及两种单克隆抗体识别的表位定位
Nucleic Acids Res. 1991 Feb 11;19(3):525-31. doi: 10.1093/nar/19.3.525.

引用本文的文献

1
Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications.治疗性靶向纤维连接蛋白在自身免疫和纤维化应用中的递药技术。
Adv Drug Deliv Rev. 2024 Jun;209:115303. doi: 10.1016/j.addr.2024.115303. Epub 2024 Apr 6.
2
The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis.细胞外基质:其组成、功能、重塑及其在肿瘤发生中的作用
Biomimetics (Basel). 2023 Apr 5;8(2):146. doi: 10.3390/biomimetics8020146.
3
Epigenetic regulation and targeting of ECM for cancer therapy.
表观遗传调控与细胞外基质靶向治疗癌症。
Am J Physiol Cell Physiol. 2022 Apr 1;322(4):C762-C768. doi: 10.1152/ajpcell.00022.2022. Epub 2022 Mar 2.
4
Extracellular matrix and its therapeutic potential for cancer treatment.细胞外基质及其在癌症治疗中的治疗潜力。
Signal Transduct Target Ther. 2021 Apr 23;6(1):153. doi: 10.1038/s41392-021-00544-0.
5
Targeting the tumor vasculature with engineered cystine-knot miniproteins.靶向肿瘤血管生成的工程化胱氨酸结微蛋白。
Nat Commun. 2020 Jan 15;11(1):295. doi: 10.1038/s41467-019-13948-y.
6
L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model.L19-IL2免疫细胞因子与抗Syndecan-1 46F2SIP抗体形式联合应用:卵巢癌模型中的一种新型靶向治疗方法。
Cancers (Basel). 2019 Aug 23;11(9):1232. doi: 10.3390/cancers11091232.
7
Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.α5β1 整联蛋白介导的内皮细胞 FN(纤连蛋白)沉积促进动脉粥样硬化炎症。
Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2601-2614. doi: 10.1161/ATVBAHA.118.311705.
8
Endothelium-derived fibronectin regulates neonatal vascular morphogenesis in an autocrine fashion.内皮细胞衍生的纤维连接蛋白以自分泌的方式调节新生儿血管形态发生。
Angiogenesis. 2017 Nov;20(4):519-531. doi: 10.1007/s10456-017-9563-8. Epub 2017 Jun 30.
9
Fibronectin Mechanobiology Regulates Tumorigenesis.纤连蛋白力学生物学调控肿瘤发生。
Cell Mol Bioeng. 2016;9:1-11. doi: 10.1007/s12195-015-0417-4. Epub 2015 Aug 15.
10
Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.尿癌胚ED-A纤维连接蛋白与膀胱癌患者的不良预后相关。
Clin Exp Metastasis. 2016 Jan;33(1):29-44. doi: 10.1007/s10585-015-9754-x. Epub 2015 Oct 11.